Evaluating the Relationship Between Tobacco Use, Anxiety Sensitivity, and Panic in Adolescents
NCT00535964 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2022-11-17
Summary
This study will determine whether there is a relationship between tobacco use and a heightened response to panic-producing events among adolescents. This study is fundamental research. It was not a Clinical Trial.
Conditions
- Panic Disorder
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
University of Arkansas, Fayetteville
lead OTHER
Principal Investigators
-
Ellen W. Leen-Feldner, PhD · University of Arkansas
Eligibility
- Min Age
- 12 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2009-04-30
- Completion
- 2009-04-30
Countries
- United States
Study Locations
More Related Trials
-
Behavioral Pharmacology of Cannabis and Nicotine
NCT04124432 ·Status: COMPLETED ·Phase: PHASE1
-
Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder
NCT00644969 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.
NCT01181934 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia
NCT00554840 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Nicotine in Tobacco Smokers
NCT03651869 ·Status: COMPLETED ·Phase: PHASE1
-
Electronic Cigarettes and Reactivity to Smoking Cues
NCT01782599 ·Status: RECRUITING ·Phase: NA
-
Reduced Nicotine Cigarette Purchasing Decisions
NCT04999644 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)
NCT01055886 ·Status: COMPLETED ·Phase: NA
-
Evaluating New Nicotine Standards for Cigarettes - Project 3
NCT03194256 ·Status: COMPLETED ·Phase: NA
-
Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders
NCT01928758 ·Status: COMPLETED ·Phase: NA
-
Effects of Varenicline on Smoking Reminders
NCT01524627 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline for Adolescent Smoking Cessation
NCT01509547 ·Status: COMPLETED ·Phase: PHASE3
-
Nicotine and Behavior in Adult ADHD
NCT00573248 ·Status: COMPLETED ·Phase: NA
-
IV Nicotine Induced Changes in Hormone Function, Mood States and Behavior
NCT01589055 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Varenicline on Reactivity to Smoking and Drinking Cues
NCT00873535 ·Status: COMPLETED ·Phase: NA
-
The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers
NCT00633256 ·Status: COMPLETED ·Phase: NA
-
Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers
NCT05335915 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacogenetics, Emotional Reactivity and Smoking
NCT00507728 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effects of Sedatives on Tobacco Use Disorder
NCT03813121 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans
NCT00616746 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Intranasal Oxytocin on Cigarette Smoking
NCT02595749 ·Status: COMPLETED ·Phase: PHASE4
-
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
NCT01535040 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Nicotine on Elements of Attentions in Smokers and Nonsmokers
NCT01034020 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
NCT00218218 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking
NCT00248118 ·Status: TERMINATED ·Phase: PHASE2/PHASE3